These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The 163-171 peptide of human IL-1 beta. Boraschi D, Ghiara P, Villa L, Antoni G, Tagliabue A. Prog Clin Biol Res; 1990; 349():365-74. PubMed ID: 2144645 [No Abstract] [Full Text] [Related]
3. Amino acids conserved in interleukin-1 receptors (IL-1Rs) and the Drosophila toll protein are essential for IL-1R signal transduction. Heguy A, Baldari CT, Macchia G, Telford JL, Melli M. J Biol Chem; 1992 Feb 05; 267(4):2605-9. PubMed ID: 1531143 [Abstract] [Full Text] [Related]
4. Binding of type I IL-1 beta receptor fragment 151-162 to interleukin-1 beta. Fasina G, Verdoliva A, Cassani G, Melli M. Growth Factors; 1994 Feb 05; 10(2):99-106. PubMed ID: 8068354 [Abstract] [Full Text] [Related]
7. An antibody to a 17 amino acid synthetic peptide of the type I interleukin-1 receptor preferentially blocks interleukin-1 beta binding. Clark BD, Ikejima T, Mancilla J, Orencole SF, Sirko SP, Ishii N, Okuda K, Dinarello CA. J Interferon Cytokine Res; 1996 Dec 05; 16(12):1079-88. PubMed ID: 8974012 [Abstract] [Full Text] [Related]
8. Synthetic C-terminal peptide of IL-1 functions as a binding domain as well as an antagonist for the IL-1 receptor. Palaszynski EW. Biochem Biophys Res Commun; 1987 Aug 31; 147(1):204-11. PubMed ID: 2958006 [Abstract] [Full Text] [Related]
10. IL-1 receptor subtypes possess distinct binding properties for IL-1 alpha and IL-1 beta. Ghiara P, Scapigliati G, Censini S, Bartalini M, Bossù P, Armellini D, Nuti S, Volpini G, Dallai R, Boraschi D. Prog Clin Biol Res; 1990 Aug 31; 349():271-84. PubMed ID: 2144641 [No Abstract] [Full Text] [Related]
11. Interleukin-1 stimulates the expression of type I and type II interleukin-1 receptors in the rat insulinoma cell line Rinm5F; sequencing a rat type II interleukin-1 receptor cDNA. Bristulf J, Gatti S, Malinowsky D, Bjork L, Sundgren AK, Bartfai T. Eur Cytokine Netw; 1994 Aug 31; 5(3):319-30. PubMed ID: 7524717 [Abstract] [Full Text] [Related]
13. Intercellular adhesion molecule-1 expression induced by interleukin (IL)-1 beta or an IL-1 beta fragment is blocked by an IL-1 receptor antagonist and a soluble IL-1 receptor. Hong L, Imeri L, Opp MR, Postlethwaite AE, Seyer JM, Krueger JM. J Neuroimmunol; 1993 May 31; 44(2):163-70. PubMed ID: 8099361 [Abstract] [Full Text] [Related]
14. Two distinct affinity binding sites for IL-1 on human cell lines. Bensimon C, Wakasugi N, Tagaya Y, Takakura K, Yodoi J, Tursz T, Wakasugi H. J Immunol; 1989 Aug 15; 143(4):1168-74. PubMed ID: 2526182 [Abstract] [Full Text] [Related]
15. Expression of IL-1 receptors on human peripheral B cells. Tanaka Y, Shirakawa F, Oda S, Eto S, Yamashita U. J Immunol; 1989 Jan 01; 142(1):167-72. PubMed ID: 2521232 [Abstract] [Full Text] [Related]
16. Interleukin-1 (IL-1) receptors on murine splenic B cells and the 70Z/3 pre-B-cell line appear to be identical and bind human IL-1 alpha and IL-1 beta differentially. Powers GD, Varnell TA, Kaffka KL, Chizzonite R, Kilian PL. Lymphokine Cytokine Res; 1992 Apr 01; 11(2):123-32. PubMed ID: 1533794 [Abstract] [Full Text] [Related]
20. A synthetic peptide corresponding to 86-93 of the human type I IL-1 receptor binds human recombinant IL-1 (alpha and beta) and inhibits IL-1 actions in vitro and in vivo. Tanihara M, Suzuki Y, Fujiwara C, Abe C, Abe E, Suda T, Mizushima Y. Biochem Biophys Res Commun; 1992 Oct 30; 188(2):912-20. PubMed ID: 1445332 [Abstract] [Full Text] [Related] Page: [Next] [New Search]